Department of Pharmacy, School of Pharmacy, University of Oslo, Oslo, Norway.
Eur J Pharm Biopharm. 2011 Jan;77(1):75-83. doi: 10.1016/j.ejpb.2010.09.010. Epub 2010 Sep 26.
The potential of liposomes as a drug delivery system for use in the oral cavity has been investigated. Specifically targeting for the teeth, the in vitro adsorption of charged liposomal formulations to hydroxyapatite (HA), a common model substance for the dental enamel, has been conducted. The experiments were performed in human parotid saliva to simulate oral-like conditions. It was observed, however, that precipitation occurred in tubes containing DPPC/DPTAP or DPPC/DPPG-liposomes in parotid saliva with no HA present, indicating that constituents of parotid saliva reacted with the liposomes. The aggregation reactions of liposome-parotid saliva mixtures were examined by turbidimetry and by atomic force microscopy. Negatively charged DPPC/DPPS and DPPC/PI-liposomes were additionally included in these experiments. The initial turbidity of positive DPPC/DPTAP-liposomes in parotid saliva was very high, but decreased markedly after 30 min. AFM images showed large aggregates of micelle-like globules known to be present in saliva. The turbidity of the various negatively charged liposome and parotid saliva mixtures stayed relatively constant throughout the measuring time; however, their initial turbidities were different; mixtures with DPPC/DPPG-liposomes were the most turbid and DPPC/DPPA-liposomes the least. Pyrophosphate (PP) was added to the various liposome-parotid saliva mixtures to examine the effect of Ca(2+) on the interactions. The effect of PP treatment of the negatively charged liposome-parotid saliva mixtures was most pronounced with DPPC/DPPG-liposome mixtures where it caused a sudden drop in turbidity. For positive DPPC/DPTAP liposome and parotid saliva mixtures, the effect of PP was minimal. These experiments showed that saliva constituents may interact with liposomes. An appropriate liposomal drug delivery system intended for use in the oral cavity seems to be dependent on the liposomal formulation. Based on the present results, negatively charged DPPC/DPPA-liposomes seem to be most suitable for use in the oral cavity as they were found to be the least reactive with the components of parotid saliva.
已经研究了脂质体作为用于口腔的药物传递系统的潜力。具体针对牙齿,已经在体外研究了带电荷的脂质体制剂在羟磷灰石(HA)上的吸附作用,HA 是牙釉质的常见模型物质。实验在人腮腺唾液中进行,以模拟口腔样条件。然而,观察到在含有 DPPC/DPTAP 或 DPPC/DPPG-脂质体的管中发生沉淀,而不存在 HA,这表明腮腺唾液中的成分与脂质体发生反应。通过浊度法和原子力显微镜检查了脂质体-腮腺唾液混合物的聚集反应。此外,还将带负电荷的 DPPC/DPPS 和 DPPC/PI-脂质体纳入这些实验中。在腮腺唾液中,带正电荷的 DPPC/DPTAP-脂质体的初始浊度非常高,但在 30 分钟后明显下降。原子力显微镜图像显示存在于唾液中的胶束状大颗粒的大聚集体。各种带负电荷的脂质体和腮腺唾液混合物的初始浊度在整个测量时间内保持相对稳定;然而,它们的初始浊度不同;含有 DPPC/DPPG-脂质体的混合物最浑浊,而含有 DPPC/DPPA-脂质体的混合物最不浑浊。向各种脂质体-腮腺唾液混合物中添加焦磷酸盐(PP),以检查 Ca(2+)对相互作用的影响。PP 处理带负电荷的 DPPC/DPPG-脂质体-腮腺唾液混合物的效果最为明显,导致浊度突然下降。对于带正电荷的 DPPC/DPTAP 脂质体和腮腺唾液混合物,PP 的影响最小。这些实验表明,唾液成分可能与脂质体相互作用。适用于口腔的适当脂质体药物传递系统似乎取决于脂质体配方。根据目前的结果,带负电荷的 DPPC/DPPA-脂质体似乎最适合用于口腔,因为它们与腮腺唾液的成分反应性最小。